DEXMETHYLPHENIDATE HYDROCHLORIDE

DEXMETHYLPHENIDATE HYDROCHLORIDE was reported 4282 times

These side effects are most commonly reported by patients taking DEXMETHYLPHENIDATE HYDROCHLORIDE:

# Side effect Count
0 DRUG INEFFECTIVE 769
1 NAUSEA 206
2 ANXIETY 199
3 HEADACHE 188
4 FATIGUE 176
5 ABNORMAL BEHAVIOUR 168
6 FEELING ABNORMAL 167
7 DECREASED APPETITE 160
8 DISTURBANCE IN ATTENTION 158
9 OFF LABEL USE 150
10 INSOMNIA 147
11 AGGRESSION 144
12 DEPRESSION 141
13 VOMITING 141
14 DIZZINESS 130
15 IRRITABILITY 118
16 SOMNOLENCE 116
17 PRODUCT SUBSTITUTION ISSUE 108
18 SUICIDAL IDEATION 106
19 WEIGHT INCREASED 104
20 MALAISE 102
21 PRODUCT DOSE OMISSION ISSUE 102
22 PRODUCT QUALITY ISSUE 102
23 ANGER 98
24 DYSPNOEA 96
25 PAIN 93
26 WEIGHT DECREASED 93
27 CONDITION AGGRAVATED 90
28 RASH 87
29 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 87
30 ABDOMINAL PAIN UPPER 82
31 TREATMENT FAILURE 81
32 CRYING 72
33 COUGH 70
34 NO ADVERSE EVENT 70
35 AGITATION 69
36 CHEST PAIN 68
37 PYREXIA 68
38 MOOD SWINGS 67
39 PALPITATIONS 67
40 ASTHENIA 65
41 HYPERHIDROSIS 65
42 PSYCHOMOTOR HYPERACTIVITY 62
43 TREMOR 62
44 BLOOD PRESSURE INCREASED 61
45 EMOTIONAL DISORDER 61
46 DIARRHOEA 60
47 HEART RATE INCREASED 59
48 PRURITUS 59
49 TIC 59
50 CONFUSIONAL STATE 58
51 HALLUCINATION 56
52 ABDOMINAL DISCOMFORT 55
53 GYNAECOMASTIA 54
54 HYPERSENSITIVITY 53
55 HYPERTENSION 53
56 LOSS OF CONSCIOUSNESS 53
57 ILLNESS 51
58 FALL 49
59 MEMORY IMPAIRMENT 49
60 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 48
61 DEPRESSED MOOD 48
62 NASOPHARYNGITIS 48
63 PARAESTHESIA 48
64 VISION BLURRED 48
65 PARANOIA 47
66 WITHDRAWAL SYNDROME 47
67 CONVULSION 46
68 PRODUCT USE IN UNAPPROVED INDICATION 46
69 MUSCLE SPASMS 45
70 SEIZURE 45
71 HYPOAESTHESIA 44
72 ARTHRALGIA 43
73 EMOTIONAL DISTRESS 43
74 INCORRECT DOSE ADMINISTERED 43
75 ERYTHEMA 42
76 PRODUCT USE ISSUE 42
77 DRUG DOSE OMISSION 41
78 INJECTION SITE PAIN 41
79 TACHYCARDIA 41
80 URTICARIA 41
81 ADVERSE DRUG REACTION 40
82 CONSTIPATION 40
83 PRODUCT PHYSICAL ISSUE 40
84 DYSPHAGIA 39
85 PRODUCT AVAILABILITY ISSUE 39
86 WRONG TECHNIQUE IN DRUG USAGE PROCESS 39
87 LETHARGY 38
88 MIGRAINE 38
89 SINUSITIS 37
90 UNEVALUABLE EVENT 37
91 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 36
92 INTENTIONAL PRODUCT MISUSE 36
93 MUSCULAR WEAKNESS 36
94 DRUG EFFECT DECREASED 35
95 MOOD ALTERED 35
96 DRY MOUTH 34
97 ABDOMINAL DISTENSION 33
98 PNEUMONIA 33
99 BACK PAIN 31
100 DRY SKIN 31
101 INFLUENZA 31
102 MEDICATION ERROR 31
103 NERVOUSNESS 31
104 SLEEP DISORDER 31
105 SWELLING FACE 31
106 ABDOMINAL PAIN 30
107 DRUG DOSE OMISSION BY DEVICE 30
108 PSYCHOTIC DISORDER 30
109 FEELING HOT 29
110 PAIN IN EXTREMITY 29
111 NECK PAIN 28
112 TARDIVE DYSKINESIA 28
113 ASTHMA 27
114 DRUG HYPERSENSITIVITY 27
115 DRUG INTOLERANCE 27
116 MUSCLE TWITCHING 27
117 OVERDOSE 27
118 THERAPEUTIC RESPONSE UNEXPECTED 27
119 TOXICITY TO VARIOUS AGENTS 27
120 VISUAL IMPAIRMENT 26
121 WHEEZING 26
122 COVID-19 25
123 DRUG INTERACTION 25
124 FEELING JITTERY 25
125 GAIT DISTURBANCE 25
126 RESTLESSNESS 25
127 CHEST DISCOMFORT 24
128 DYSKINESIA 24
129 GASTROOESOPHAGEAL REFLUX DISEASE 24
130 HYPOPHAGIA 23
131 INTENTIONAL PRODUCT USE ISSUE 23
132 PRODUCT DOSE OMISSION 23
133 THERAPEUTIC PRODUCT EFFECT DECREASED 23
134 DRUG PRESCRIBING ERROR 22
135 FEAR 22
136 INFECTION 22
137 NEUROLOGICAL SYMPTOM 22
138 PULSE ABNORMAL 22
139 AMENORRHOEA 21
140 BRAIN INJURY 21
141 DEHYDRATION 21
142 SOMATIC SYMPTOM DISORDER 21
143 AMNESIA 20
144 CLAUSTROPHOBIA 20
145 CONTUSION 20
146 DEVICE BREAKAGE 20
147 EDUCATIONAL PROBLEM 20
148 GASTROINTESTINAL DISORDER 20
149 GROWTH RETARDATION 20
150 HYPERREFLEXIA 20
151 HYPERTENSIVE CRISIS 20
152 LIVER INJURY 20
153 MENTAL DISORDER 20
154 OROPHARYNGEAL PAIN 20
155 PANIC ATTACK 20
156 THERAPEUTIC RESPONSE SHORTENED 20
157 APPLICATION SITE ERYTHEMA 19
158 EAR INFECTION 19
159 NIGHTMARE 19
160 PRE-EXISTING CONDITION IMPROVED 19
161 SPEECH DISORDER 19
162 SUICIDE ATTEMPT 19
163 URINARY TRACT INFECTION 19
164 ATTENTION DEFICIT HYPERACTIVITY DISORDER 18
165 BIPOLAR DISORDER 18
166 BRONCHITIS 18
167 DRUG DISPENSING ERROR 18
168 IMPULSIVE BEHAVIOUR 18
169 INTENTIONAL DOSE OMISSION 18
170 MYDRIASIS 18
171 PRESCRIBED OVERDOSE 18
172 RETCHING 18
173 THERAPY NON-RESPONDER 18
174 ADULTERATED PRODUCT 17
175 DEVICE ISSUE 17
176 DRUG ADMINISTRATION ERROR 17
177 EATING DISORDER 17
178 GENERAL PHYSICAL HEALTH DETERIORATION 17
179 HALLUCINATION, AUDITORY 17
180 HALLUCINATION, VISUAL 17
181 HYPOTENSION 17
182 INSURANCE ISSUE 17
183 PHARYNGITIS STREPTOCOCCAL 17
184 PRODUCT TAMPERING 17
185 SEDATION 17
186 SKIN EXFOLIATION 17
187 SYNCOPE 17
188 THERAPY CESSATION 17
189 APPLICATION SITE PRURITUS 16
190 DEATH 16
191 DRUG WITHDRAWAL SYNDROME 16
192 EPISTAXIS 16
193 MIDDLE INSOMNIA 16
194 MYALGIA 16
195 RHINORRHOEA 16
196 SCREAMING 16
197 SLEEP APNOEA SYNDROME 16
198 AUTISM SPECTRUM DISORDER 15
199 BEHAVIOUR DISORDER 15
200 CHILLS 15
201 DRUG DEPENDENCE 15
202 OBSESSIVE-COMPULSIVE DISORDER 15
203 POLLAKIURIA 15
204 SKIN DISCOLOURATION 15
205 UNDERDOSE 15
206 ACNE 14
207 AFFECTIVE DISORDER 14
208 ECZEMA 14
209 INCORRECT DRUG ADMINISTRATION DURATION 14
210 INITIAL INSOMNIA 14
211 MOVEMENT DISORDER 14
212 SURGERY 14
213 THERAPY INTERRUPTED 14
214 URINARY INCONTINENCE 14
215 DERMATITIS ATOPIC 13
216 DISORIENTATION 13
217 DISTURBANCE IN SOCIAL BEHAVIOUR 13
218 DYSPEPSIA 13
219 DYSTONIA 13
220 FLUSHING 13
221 HOSPITALISATION 13
222 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 13
223 INJECTION SITE BRUISING 13
224 INJURY 13
225 OBESITY 13
226 PRODUCT USE COMPLAINT 13
227 ROAD TRAFFIC ACCIDENT 13
228 STRESS 13
229 THINKING ABNORMAL 13
230 ACCIDENTAL EXPOSURE TO PRODUCT 12
231 ALOPECIA 12
232 BLOOD GLUCOSE INCREASED 12
233 BLOOD PRESSURE DECREASED 12
234 DRUG ADMINISTERED AT INAPPROPRIATE SITE 12
235 DRUG EFFECT LESS THAN EXPECTED 12
236 ENURESIS 12
237 GASTROENTERITIS VIRAL 12
238 HEAD INJURY 12
239 INCREASED APPETITE 12
240 INTENTIONAL SELF-INJURY 12
241 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12
242 MANIA 12
243 NEPHROLITHIASIS 12
244 OEDEMA PERIPHERAL 12
245 PERFORMANCE STATUS DECREASED 12
246 RASH MACULAR 12
247 SOCIAL AVOIDANT BEHAVIOUR 12
248 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12
249 THERAPEUTIC RESPONSE DECREASED 12
250 UPPER RESPIRATORY TRACT INFECTION 12
251 WHITE BLOOD CELL COUNT DECREASED 12
252 ABNORMAL WEIGHT GAIN 11
253 ADVERSE EVENT 11
254 ANAPHYLACTIC REACTION 11
255 APPLICATION SITE IRRITATION 11
256 BRAIN FOG 11
257 COGNITIVE DISORDER 11
258 COLD SWEAT 11
259 DISCOMFORT 11
260 DRY EYE 11
261 DYSARTHRIA 11
262 EAR PAIN 11
263 EXTRA DOSE ADMINISTERED 11
264 HEPATIC ENZYME INCREASED 11
265 HYPERSOMNIA 11
266 MENTAL IMPAIRMENT 11
267 PERSONALITY CHANGE 11
268 PRODUCT ADHESION ISSUE 11
269 TREATMENT NONCOMPLIANCE 11
270 VIRAL INFECTION 11
271 AFFECT LABILITY 10
272 BALANCE DISORDER 10
273 CYANOSIS 10
274 ENERGY INCREASED 10
275 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 10
276 INJECTION SITE HAEMORRHAGE 10
277 PALLOR 10
278 PRODUCT PRESCRIBING ERROR 10
279 SKIN BURNING SENSATION 10
280 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 10
281 THERAPEUTIC RESPONSE CHANGED 10
282 THIRST 10
283 ANAEMIA 9
284 APPETITE DISORDER 9
285 CEREBROVASCULAR ACCIDENT 9
286 DEVICE INFORMATION OUTPUT ISSUE 9
287 DEVICE MALFUNCTION 9
288 DRUG TOLERANCE 9
289 EXPOSURE DURING PREGNANCY 9
290 FORMICATION 9
291 HALLUCINATIONS, MIXED 9
292 HUNGER 9
293 ILL-DEFINED DISORDER 9
294 INFLUENZA LIKE ILLNESS 9
295 INTENTIONAL OVERDOSE 9
296 MICTURITION URGENCY 9
297 OCULAR HYPERAEMIA 9
298 OSTEOPOROSIS 9
299 PERIPHERAL COLDNESS 9
300 PERIPHERAL SWELLING 9
301 PLATELET COUNT DECREASED 9
302 PRESYNCOPE 9
303 PRODUCT ADMINISTRATION INTERRUPTED 9
304 PRODUCT DISPENSING ERROR 9
305 PRODUCT PACKAGING QUANTITY ISSUE 9
306 PSORIASIS 9
307 SEROTONIN SYNDROME 9
308 SLEEP TERROR 9
309 SOMNAMBULISM 9
310 VERTIGO 9
311 ACCIDENTAL OVERDOSE 8
312 ALANINE AMINOTRANSFERASE INCREASED 8
313 APATHY 8
314 AUTISM 8
315 BLOOD CHOLESTEROL INCREASED 8
316 BRUXISM 8
317 COELIAC DISEASE 8
318 CYSTIC FIBROSIS 8
319 DEVICE LEAKAGE 8
320 DEVICE MECHANICAL ISSUE 8
321 DIABETES MELLITUS 8
322 DISEASE RECURRENCE 8
323 DISTRACTIBILITY 8
324 DRUG DIVERSION 8
325 DYSGEUSIA 8
326 DYSPHONIA 8
327 DYSURIA 8
328 FIBROMYALGIA 8
329 HYPOTHYROIDISM 8
330 IMPAIRED QUALITY OF LIFE 8
331 JOINT INJURY 8
332 MOBILITY DECREASED 8
333 MULTIPLE SCLEROSIS RELAPSE 8
334 MYOCARDIAL INFARCTION 8
335 NASAL CONGESTION 8
336 PRODUCT COMPLAINT 8
337 PRODUCT DOSE OMISSION IN ERROR 8
338 PRODUCT STORAGE ERROR 8
339 PRODUCTIVE COUGH 8
340 RASH PRURITIC 8
341 RHEUMATOID ARTHRITIS 8
342 SELF INJURIOUS BEHAVIOUR 8
343 SUICIDAL BEHAVIOUR 8
344 SWELLING 8
345 UNRESPONSIVE TO STIMULI 8
346 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 8
347 ABNORMAL DREAMS 7
348 ARTHRITIS 7
349 BLINDNESS 7
350 BLISTER 7
351 BLOOD ALKALINE PHOSPHATASE INCREASED 7
352 BLOOD PRESSURE ABNORMAL 7
353 BODY TEMPERATURE INCREASED 7
354 BRADYCARDIA 7
355 CATAPLEXY 7
356 CONTRAINDICATED PRODUCT ADMINISTERED 7
357 CROUP INFECTIOUS 7
358 DECREASED INTEREST 7
359 DEEP VEIN THROMBOSIS 7
360 DEPRESSED LEVEL OF CONSCIOUSNESS 7
361 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 7
362 DRUG EFFECT INCOMPLETE 7
363 DRUG LEVEL DECREASED 7
364 DYSPHEMIA 7
365 ERECTION INCREASED 7
366 EUPHORIC MOOD 7
367 EXTRAPYRAMIDAL DISORDER 7
368 EYE PAIN 7
369 EYE SWELLING 7
370 FEEDING DISORDER 7
371 FEELING COLD 7
372 FRUSTRATION TOLERANCE DECREASED 7
373 GRAND MAL CONVULSION 7
374 HAEMORRHAGE 7
375 HEART RATE DECREASED 7
376 HOMICIDAL IDEATION 7
377 IMPULSE-CONTROL DISORDER 7
378 INABILITY TO AFFORD MEDICATION 7
379 INCORRECT ROUTE OF DRUG ADMINISTRATION 7
380 INJECTION SITE REACTION 7
381 INTERVERTEBRAL DISC PROTRUSION 7
382 LIMB DISCOMFORT 7
383 LOGORRHOEA 7
384 MAJOR DEPRESSION 7
385 METABOLIC DISORDER 7
386 MUSCULOSKELETAL STIFFNESS 7
387 OXYGEN SATURATION DECREASED 7
388 POOR QUALITY DEVICE USED 7
389 PRODUCT TASTE ABNORMAL 7
390 REBOUND EFFECT 7
391 SKIN IRRITATION 7
392 STAPHYLOCOCCAL INFECTION 7
393 STEVENS-JOHNSON SYNDROME 7
394 STOMATITIS 7
395 SUPRAVENTRICULAR TACHYCARDIA 7
396 SWOLLEN TONGUE 7
397 SYSTEMIC LUPUS ERYTHEMATOSUS 7
398 THROAT IRRITATION 7
399 THROAT TIGHTNESS 7
400 UPPER-AIRWAY COUGH SYNDROME 7
401 VISUAL ACUITY REDUCED 7
402 WEIGHT GAIN POOR 7
403 WRONG PRODUCT ADMINISTERED 7
404 AKATHISIA 6
405 AMPHETAMINES POSITIVE 6
406 ANXIETY DISORDER 6
407 APPLICATION SITE PAIN 6
408 BLEPHAROSPASM 6
409 BURNING SENSATION 6
410 CARDIAC DISORDER 6
411 CEREBRAL DISORDER 6
412 CHRONIC KIDNEY DISEASE 6
413 CONCUSSION 6
414 COORDINATION ABNORMAL 6
415 DELUSION 6
416 DIPLOPIA 6
417 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6
418 ELECTROCARDIOGRAM QT PROLONGED 6
419 EPILEPSY 6
420 EXCESSIVE EYE BLINKING 6
421 EXPIRED DEVICE USED 6
422 EXPIRED PRODUCT ADMINISTERED 6
423 EYE MOVEMENT DISORDER 6
424 FOOD ALLERGY 6
425 GAIT INABILITY 6
426 HEAD DISCOMFORT 6
427 HERPES ZOSTER 6
428 HOSTILITY 6
429 HYPERPHAGIA 6
430 INFUSION RELATED REACTION 6
431 INJECTION SITE SWELLING 6
432 LIP SWELLING 6
433 MENSTRUATION IRREGULAR 6
434 NERVOUS SYSTEM DISORDER 6
435 OPPOSITIONAL DEFIANT DISORDER 6
436 ORAL PAIN 6
437 OSTEOPENIA 6
438 PANIC REACTION 6
439 PETIT MAL EPILEPSY 6
440 POOR QUALITY SLEEP 6
441 PRODUCT COLOUR ISSUE 6
442 RASH ERYTHEMATOUS 6
443 RASH GENERALISED 6
444 RAYNAUD'S PHENOMENON 6
445 RENAL FAILURE 6
446 SKIN LACERATION 6
447 SNORING 6
448 THERAPY CHANGE 6
449 WHITE BLOOD CELL COUNT INCREASED 6
450 ABORTION SPONTANEOUS 5
451 ANHEDONIA 5
452 ANKLE FRACTURE 5
453 ANOREXIA 5
454 ANTISOCIAL BEHAVIOUR 5
455 APHASIA 5
456 BLOOD CREATINE PHOSPHOKINASE INCREASED 5
457 BLOOD PROLACTIN INCREASED 5
458 CARDIAC ARREST 5
459 CELLULITIS 5
460 CHROMATURIA 5
461 DARK CIRCLES UNDER EYES 5
462 DEVICE DISLOCATION 5
463 DEVICE USE ERROR 5
464 DISEASE PROGRESSION 5
465 DRUG ABUSE 5
466 DRUG SCREEN NEGATIVE 5
467 DYSMENORRHOEA 5
468 ECONOMIC PROBLEM 5
469 FUNGAL INFECTION 5
470 GALACTORRHOEA 5
471 GASTRIC DISORDER 5
472 GLOSSODYNIA 5
473 HAEMOPTYSIS 5
474 HOT FLUSH 5
475 HYPERMETABOLISM 5
476 HYPERPROLACTINAEMIA 5
477 HYPOKALAEMIA 5
478 IMPAIRED WORK ABILITY 5
479 INCONTINENCE 5
480 INFUSION SITE EXTRAVASATION 5
481 INJECTION SITE ERYTHEMA 5
482 INJECTION SITE URTICARIA 5
483 INTENTIONAL DRUG MISUSE 5
484 INTESTINAL OBSTRUCTION 5
485 JOINT SWELLING 5
486 LIQUID PRODUCT PHYSICAL ISSUE 5
487 LUNG DISORDER 5
488 MATERNAL EXPOSURE DURING PREGNANCY 5
489 MENORRHAGIA 5
490 MULTIPLE SCLEROSIS 5
491 MUSCLE RIGIDITY 5
492 MUSCLE TIGHTNESS 5
493 NEEDLE ISSUE 5
494 NEGATIVE THOUGHTS 5
495 NEURALGIA 5
496 NEUROPATHY PERIPHERAL 5
497 NEUTROPHIL COUNT DECREASED 5
498 NO THERAPEUTIC RESPONSE 5
499 OEDEMA 5
500 PAIN OF SKIN 5
501 PHARMACEUTICAL PRODUCT COMPLAINT 5
502 POOR VENOUS ACCESS 5
503 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 5
504 PRIAPISM 5
505 PRODUCT ADMINISTRATION ERROR 5
506 PRODUCT FORMULATION ISSUE 5
507 PRODUCT SIZE ISSUE 5
508 PRURITUS GENERALISED 5
509 PULMONARY EMBOLISM 5
510 RESPIRATORY DISORDER 5
511 RESPIRATORY DISTRESS 5
512 RESPIRATORY TRACT INFECTION 5
513 RHABDOMYOLYSIS 5
514 SCOLIOSIS 5
515 SINUS DISORDER 5
516 SKIN FISSURES 5
517 STARING 5
518 SYRINGE ISSUE 5
519 TENSION 5
520 TONGUE DISORDER 5
521 ULCER 5
522 UNDERWEIGHT 5
523 UPPER LIMB FRACTURE 5
524 WEIGHT FLUCTUATION 5
525 ALLERGIC REACTION TO EXCIPIENT 4
526 APNOEA 4
527 ARTHROPATHY 4
528 ASPARTATE AMINOTRANSFERASE INCREASED 4
529 ATRIAL FIBRILLATION 4
530 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4
531 AUTOIMMUNE DISORDER 4
532 BLOOD GLUCOSE DECREASED 4
533 BLOOD PRESSURE FLUCTUATION 4
534 BODY TEMPERATURE DECREASED 4
535 BREAST ENLARGEMENT 4
536 CENTRAL VENOUS CATHETERISATION 4
537 CHOKING 4
538 CHOLECYSTECTOMY 4
539 CHOLECYSTITIS CHRONIC 4
540 CHOLELITHIASIS 4
541 COLITIS 4
542 COMMUNICATION DISORDER 4
543 COMPLETED SUICIDE 4
544 COMPLICATION ASSOCIATED WITH DEVICE 4
545 COMPLICATION OF DEVICE REMOVAL 4
546 CONVERSION DISORDER 4
547 CRANIOCEREBRAL INJURY 4
548 CYSTITIS 4
549 DERMATILLOMANIA 4
550 DERMATITIS CONTACT 4
551 DIABETIC KETOACIDOSIS 4
552 DROOLING 4
553 DRUG SCREEN POSITIVE 4
554 DRY THROAT 4
555 ELECTROCARDIOGRAM ABNORMAL 4
556 EXPOSURE VIA SKIN CONTACT 4
557 FLATULENCE 4
558 FOAMING AT MOUTH 4
559 GALLBLADDER DISORDER 4
560 GENERALISED ERYTHEMA 4
561 GLUCOSE TOLERANCE IMPAIRED 4
562 HAEMOGLOBIN DECREASED 4
563 HANGOVER 4
564 HEART RATE IRREGULAR 4
565 HENOCH-SCHONLEIN PURPURA 4
566 HYPERCHOLESTEROLAEMIA 4
567 HYPOACUSIS 4
568 IMPAIRED GASTRIC EMPTYING 4
569 INFLAMMATION 4
570 INFUSION SITE PAIN 4
571 INJECTION SITE MASS 4
572 IRRITABLE BOWEL SYNDROME 4
573 LEARNING DISORDER 4
574 LUNG INFECTION 4
575 MENTAL STATUS CHANGES 4
576 MULTIPLE ALLERGIES 4
577 NARCOLEPSY 4
578 NEGATIVISM 4
579 NEOPLASM PROGRESSION 4
580 NERVE COMPRESSION 4
581 NIGHT SWEATS 4
582 NON-CARDIAC CHEST PAIN 4
583 OBSTRUCTIVE SLEEP APNOEA SYNDROME 4
584 OVERWEIGHT 4
585 PAIN IN JAW 4
586 PANCREATITIS 4
587 PARADOXICAL DRUG REACTION 4
588 PHARYNGITIS 4
589 PHOTOPHOBIA 4
590 PROCEDURAL PAIN 4
591 PRODUCT SOLUBILITY ABNORMAL 4
592 PSORIATIC ARTHROPATHY 4
593 RECALLED PRODUCT ADMINISTERED 4
594 RESPIRATORY RATE INCREASED 4
595 RESTLESS LEGS SYNDROME 4
596 SCAR 4
597 SCHIZOPHRENIA 4
598 SEASONAL ALLERGY 4
599 SELF-INJURIOUS IDEATION 4
600 SEXUAL DYSFUNCTION 4
601 SINUS CONGESTION 4
602 SKIN HAEMORRHAGE 4
603 SKIN LESION 4
604 SKIN PLAQUE 4
605 SLEEP DEFICIT 4
606 SOCIAL ANXIETY DISORDER 4
607 SOCIAL PROBLEM 4
608 STREPTOCOCCAL INFECTION 4
609 TACHYPHRENIA 4
610 TEARFULNESS 4
611 TERMINAL INSOMNIA 4
612 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 4
613 THROAT CLEARING 4
614 THROMBOSIS 4
615 TINNITUS 4
616 TOURETTE'S DISORDER 4
617 TOURETTE^S DISORDER 4
618 TYPE 2 DIABETES MELLITUS 4
619 VISUAL DISTURBANCE 4
620 VITAMIN D DECREASED 4
621 ABASIA 3
622 ABNORMAL SLEEP-RELATED EVENT 3
623 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 3
624 ACUTE KIDNEY INJURY 3
625 ANGIOPATHY 3
626 APPARENT DEATH 3
627 ARRHYTHMIA 3
628 BEDRIDDEN 3
629 BELLIGERENCE 3
630 BLOOD CALCIUM INCREASED 3
631 BLOOD CREATININE DECREASED 3
632 BLOOD PHOSPHORUS DECREASED 3
633 BLOOD SODIUM DECREASED 3
634 BLOOD TRIGLYCERIDES INCREASED 3
635 BLOOD UREA INCREASED 3
636 BLUNTED AFFECT 3
637 BODY HEIGHT INCREASED 3
638 BONE DEVELOPMENT ABNORMAL 3
639 BONE PAIN 3
640 BREAST CANCER 3
641 BREAST MASS 3
642 CARBON DIOXIDE INCREASED 3
643 CATARACT 3
644 CATHETER SITE ERYTHEMA 3
645 CATHETER SITE HAEMORRHAGE 3
646 CATHETER SITE PRURITUS 3
647 CHANGE IN SUSTAINED ATTENTION 3
648 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3
649 CLOSTRIDIUM DIFFICILE INFECTION 3
650 CLUMSINESS 3
651 CLUSTER HEADACHE 3
652 COMA 3
653 CYST 3
654 DEAFNESS 3
655 DEFIANT BEHAVIOUR 3
656 DELIRIUM 3
657 DENTAL CARE 3
658 DEPRESSION SUICIDAL 3
659 DEVICE DIFFICULT TO USE 3
660 DEVICE EXPULSION 3
661 DEVICE PHYSICAL PROPERTY ISSUE 3
662 DEVICE POWER SOURCE ISSUE 3
663 DISABILITY 3
664 DISINHIBITION 3
665 DISSOCIATION 3
666 DRUG EFFECT DELAYED 3
667 DRUG EFFECT VARIABLE 3
668 DRUG LEVEL INCREASED 3
669 DYSGRAPHIA 3
670 DYSLEXIA 3
671 DYSSTASIA 3
672 EAR DISCOMFORT 3
673 ERECTILE DYSFUNCTION 3
674 ERUCTATION 3
675 EXCORIATION 3
676 EXOPHTHALMOS 3
677 EYE DISORDER 3
678 EYE IRRITATION 3
679 EYE PRURITUS 3
680 EYELID OEDEMA 3
681 FEAR OF INJECTION 3
682 FEELING DRUNK 3
683 FEMUR FRACTURE 3
684 FOOT FRACTURE 3
685 FULL BLOOD COUNT ABNORMAL 3
686 GASTRITIS 3
687 GENERALISED ANXIETY DISORDER 3
688 GENERALISED TONIC-CLONIC SEIZURE 3
689 GRIMACING 3
690 HAEMATOCRIT DECREASED 3
691 HEPATITIS B 3
692 HEREDITARY ANGIOEDEMA 3
693 HERNIA 3
694 HIATUS HERNIA 3
695 HORMONE LEVEL ABNORMAL 3
696 HYPERGLYCAEMIA 3
697 HYPOKINESIA 3
698 HYPOMANIA 3
699 HYSTERECTOMY 3
700 ILLUSION 3
701 IMPAIRED DRIVING ABILITY 3
702 IMPAIRED HEALING 3
703 INCORRECT DRUG ADMINISTRATION RATE 3
704 INCORRECT PRODUCT ADMINISTRATION DURATION 3
705 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3
706 INSULIN RESISTANCE 3
707 INTERCEPTED DRUG DISPENSING ERROR 3
708 JOINT DISLOCATION 3
709 KNEE OPERATION 3
710 LEUKOPENIA 3
711 LIMB INJURY 3
712 LIP PAIN 3
713 LIPASE INCREASED 3
714 LIVER DISORDER 3
715 LIVER FUNCTION TEST ABNORMAL 3
716 LYMPHADENOPATHY 3
717 LYMPHOCYTE COUNT DECREASED 3
718 MACULAR DEGENERATION 3
719 MUSCLE CONTRACTIONS INVOLUNTARY 3
720 MUSCLE SPASTICITY 3
721 MUSCULOSKELETAL DISORDER 3
722 NODULE 3
723 NONSPECIFIC REACTION 3
724 OCULOGYRIC CRISIS 3
725 OEDEMA MOUTH 3
726 ONYCHOPHAGIA 3
727 OTITIS MEDIA 3
728 PANIC DISORDER 3
729 PERIPHERAL VASCULAR DISORDER 3
730 PERSONALITY DISORDER 3
731 PHARYNGEAL OEDEMA 3
732 PNEUMONIA STAPHYLOCOCCAL 3
733 POLYURIA 3
734 PREGNANCY 3
735 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 3
736 PRODUCT LABEL ISSUE 3
737 PRODUCT LOT NUMBER ISSUE 3
738 PRODUCT ODOUR ABNORMAL 3
739 PRODUCT PREPARATION ERROR 3
740 PSYCHIATRIC SYMPTOM 3
741 PSYCHOTIC BEHAVIOUR 3
742 QUALITY OF LIFE DECREASED 3
743 RECTAL HAEMORRHAGE 3
744 RED BLOOD CELL COUNT INCREASED 3
745 RENAL DISORDER 3
746 RESPIRATORY ARREST 3
747 ROTATOR CUFF SYNDROME 3
748 SCRATCH 3
749 SKIN HYPERPIGMENTATION 3
750 SKIN ULCER 3
751 SLUGGISHNESS 3
752 SPINAL FUSION SURGERY 3
753 SPINAL OSTEOARTHRITIS 3
754 STRABISMUS 3
755 SUDDEN ONSET OF SLEEP 3
756 THERAPEUTIC PRODUCT EFFECT VARIABLE 3
757 THROMBOCYTOPENIA 3
758 TINEA INFECTION 3
759 TOOTH DISORDER 3
760 TOOTHACHE 3
761 TRISMUS 3
762 TYPE 1 DIABETES MELLITUS 3
763 URINARY RETENTION 3
764 VENTRICULAR FIBRILLATION 3
765 VITAMIN D DEFICIENCY 3
766 WRIST FRACTURE 3
767 WRONG DRUG ADMINISTERED 3
768 YAWNING 3
769 ABDOMINAL PAIN LOWER 2
770 ABNORMAL FAECES 2
771 ACCIDENT 2
772 ACCIDENT AT WORK 2
773 ACCIDENTAL UNDERDOSE 2
774 ACTIVITIES OF DAILY LIVING IMPAIRED 2
775 ACUTE MYOCARDIAL INFARCTION 2
776 ACUTE RESPIRATORY FAILURE 2
777 ADHESIVE TAPE USE 2
778 ADVERSE REACTION 2
779 ALTERED VISUAL DEPTH PERCEPTION 2
780 AMYLASE INCREASED 2
781 AMYOTROPHIC LATERAL SCLEROSIS 2
782 ANAPHYLACTIC SHOCK 2
783 ANGINA PECTORIS 2
784 APLASTIC ANAEMIA 2
785 APPENDICITIS 2
786 APPLICATION SITE DISCOLOURATION 2
787 APPLICATION SITE HAEMORRHAGE 2
788 APPLICATION SITE INFLAMMATION 2
789 APPLICATION SITE RASH 2
790 ASPIRATION 2
791 ATONIC SEIZURES 2
792 ATRIOVENTRICULAR BLOCK SECOND DEGREE 2
793 ATYPICAL PNEUMONIA 2
794 BACK DISORDER 2
795 BACK INJURY 2
796 BACTERAEMIA 2
797 BACTERIAL INFECTION 2
798 BACTERIAL VAGINOSIS 2
799 BASAL CELL CARCINOMA 2
800 BENIGN INTRACRANIAL HYPERTENSION 2
801 BILIARY COLIC 2
802 BLADDER DISCOMFORT 2
803 BLADDER SPASM 2
804 BLINDNESS TRANSIENT 2
805 BLOOD CREATININE INCREASED 2
806 BLOOD PRESSURE DIASTOLIC DECREASED 2
807 BLOOD PRESSURE SYSTOLIC INCREASED 2
808 BLOOD TEST ABNORMAL 2
809 BLOOD TESTOSTERONE DECREASED 2
810 BONE DENSITY DECREASED 2
811 BONE DISORDER 2
812 BONE LOSS 2
813 BOREDOM 2
814 BREAST PAIN 2
815 BREATH ODOUR 2
816 BRONCHIECTASIS 2
817 BRUGADA SYNDROME 2
818 BULLOUS HAEMORRHAGIC DERMATOSIS 2
819 CAPSULE PHYSICAL ISSUE 2
820 CARDIAC FAILURE 2
821 CARDIAC MURMUR 2
822 CARDIOMYOPATHY 2
823 CATHETER SITE PAIN 2
824 CEREBRAL HAEMORRHAGE 2
825 CEREBRAL PALSY 2
826 CHOLECYSTITIS 2
827 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2
828 CIRCULATORY COLLAPSE 2
829 CLUBBING 2
830 COLITIS ULCERATIVE 2
831 COMPULSIVE SHOPPING 2
832 CONJUNCTIVITIS 2
833 CORONARY ARTERY DISEASE 2
834 COSTOCHONDRITIS 2
835 CREPITATIONS 2
836 CROHN'S DISEASE 2
837 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 2
838 CYSTITIS INTERSTITIAL 2
839 DAYDREAMING 2
840 DEAFNESS BILATERAL 2
841 DEFORMITY 2
842 DEPENDENCE 2
843 DEREALISATION 2
844 DEVELOPMENTAL DELAY 2
845 DEVELOPMENTAL REGRESSION 2
846 DEVICE ADHESION ISSUE 2
847 DEVICE DEFECTIVE 2
848 DEVICE DEPLOYMENT ISSUE 2
849 DEVICE FAILURE 2
850 DEVICE OCCLUSION 2
851 DEVICE RELATED INFECTION 2
852 DIABETIC COMA 2
853 DIABETIC NEUROPATHY 2
854 DISRUPTIVE MOOD DYSREGULATION DISORDER 2
855 DRUG EFFECT INCREASED 2
856 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2
857 DRUG EXPOSURE DURING PREGNANCY 2
858 DRUG SPECIFIC ANTIBODY PRESENT 2
859 DRUG TOLERANCE DECREASED 2
860 DRUG TOXICITY 2
861 DRUG WITHDRAWAL HEADACHE 2
862 DUODENOGASTRIC REFLUX 2
863 DYSPRAXIA 2
864 EAR DISORDER 2
865 EAR SWELLING 2
866 EMOTIONAL POVERTY 2
867 ENCEPHALITIS AUTOIMMUNE 2
868 ESSENTIAL HYPERTENSION 2
869 EXERCISE TOLERANCE DECREASED 2
870 EXTRASYSTOLES 2
871 EYE INFECTION 2
872 EYE ROLLING 2
873 FACE INJURY 2
874 FACIAL PAIN 2
875 FAECES SOFT 2
876 FEBRILE CONVULSION 2
877 FEELING GUILTY 2
878 FINE MOTOR SKILL DYSFUNCTION 2
879 FISTULA 2
880 FLANK PAIN 2
881 FLUID RETENTION 2
882 FOETAL EXPOSURE DURING PREGNANCY 2
883 FOOT DEFORMITY 2
884 FOOT OPERATION 2
885 FOREIGN BODY 2
886 FRUSTRATION 2
887 FURUNCLE 2
888 GASTRIC ULCER 2
889 GASTROENTERITIS 2
890 GASTROINTESTINAL HAEMORRHAGE 2
891 GASTROINTESTINAL INFECTION 2
892 GASTROINTESTINAL MOTILITY DISORDER 2
893 GLAUCOMA 2
894 GLUCOSE URINE PRESENT 2
895 GRANULOCYTOPENIA 2
896 HAEMATEMESIS 2
897 HAIR PLUCKING 2
898 HAND FRACTURE 2
899 HAND-EYE COORDINATION IMPAIRED 2
900 HAND-FOOT-AND-MOUTH DISEASE 2
901 HEAD BANGING 2
902 HEART RATE ABNORMAL 2
903 HEMIPARESIS 2
904 HEMIPLEGIA 2
905 HEPATOMEGALY 2
906 HYPERACUSIS 2
907 HYPERAEMIA 2
908 HYPERTHERMIA 2
909 HYPERVENTILATION 2
910 HYPOAESTHESIA ORAL 2
911 HYPOGLYCAEMIA 2
912 HYPONATRAEMIA 2
913 HYPOTHERMIA 2
914 HYPOTONIA 2
915 IDIOPATHIC THROMBOCYTOPENIC PURPURA 2
916 IMMUNE SYSTEM DISORDER 2
917 IMMUNOSUPPRESSION 2
918 IMPLANT SITE PAIN 2
919 INAPPROPRIATE AFFECT 2
920 INCORRECT PRODUCT STORAGE 2
921 INCORRECT STORAGE OF DRUG 2
922 INCREASED TENDENCY TO BRUISE 2
923 INFECTIOUS MONONUCLEOSIS 2
924 INFUSION SITE MASS 2
925 INJECTION SITE EXTRAVASATION 2
926 INJECTION SITE RASH 2
927 INTELLIGENCE TEST ABNORMAL 2
928 INTENTIONAL UNDERDOSE 2
929 JAUNDICE 2
930 JAW DISORDER 2
931 JOINT STIFFNESS 2
932 KNEE DEFORMITY 2
933 LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR 2
934 LACERATION 2
935 LACRIMATION INCREASED 2
936 LIBIDO DECREASED 2
937 LIBIDO INCREASED 2
938 LIMB OPERATION 2
939 LIP BLISTER 2
940 LOSS OF EMPLOYMENT 2
941 LOWER LIMB FRACTURE 2
942 LYMPHOPENIA 2
943 MASS 2
944 MENSTRUAL DISORDER 2
945 METRORRHAGIA 2
946 MOANING 2
947 MOTOR DYSFUNCTION 2
948 MOUTH ULCERATION 2
949 MUSCULOSKELETAL PAIN 2
950 MYASTHENIA GRAVIS 2
951 NAIL DISORDER 2
952 NAIL PICKING 2
953 NASAL DISCOMFORT 2
954 NASAL DRYNESS 2
955 NEAR DEATH EXPERIENCE 2
956 NEOPLASM 2
957 NEUROLEPTIC MALIGNANT SYNDROME 2
958 NEUTROPENIA 2
959 NEUTROPHIL COUNT INCREASED 2
960 NOCTURIA 2
961 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 2
962 OBSESSIVE THOUGHTS 2
963 OCULAR DISCOMFORT 2
964 OCULAR NEOPLASM 2
965 OPIATES POSITIVE 2
966 ORAL HERPES 2
967 ORTHOSTATIC HYPOTENSION 2
968 OSTEONECROSIS 2
969 OVERGROWTH BACTERIAL 2
970 PAINFUL ERECTION 2
971 PANCREATITIS ACUTE 2
972 PARALYSIS 2
973 PARKINSON'S DISEASE 2
974 PENILE PAIN 2
975 PERICARDIAL EFFUSION 2
976 PETECHIAE 2
977 PLEURAL EFFUSION 2
978 PLEURISY 2
979 POLYCYSTIC OVARIAN SYNDROME 2
980 POLYMENORRHOEA 2
981 POOR QUALITY DRUG ADMINISTERED 2
982 POST PROCEDURAL COMPLICATION 2
983 POTENTIATING DRUG INTERACTION 2
984 PREMATURE BABY 2
985 PREMENSTRUAL DYSPHORIC DISORDER 2
986 PRESCRIBED UNDERDOSE 2
987 PRODUCT APPEARANCE CONFUSION 2
988 PRODUCT CONTAMINATION CHEMICAL 2
989 PRODUCT MEASURED POTENCY ISSUE 2
990 PRODUCT PACKAGING ISSUE 2
991 PRODUCT PREPARATION ISSUE 2
992 PRODUCT RESIDUE PRESENT 2
993 PRODUCT SUPPLY ISSUE 2
994 PSEUDOMONAS INFECTION 2
995 PSEUDOMONAS TEST POSITIVE 2
996 PSYCHOTIC SYMPTOM 2
997 PURPURA 2
998 RASH MACULO-PAPULAR 2
999 RASH PAPULAR 2